PUBLISHER: GlobalData | PRODUCT CODE: 1410909
PUBLISHER: GlobalData | PRODUCT CODE: 1410909
Infusion Pumps Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within Drug Delivery Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Infusion Pumps market for the year 2020 and beyond. An infusion pump is a commonly used medical device present in hospitals, homes, and healthcare centers for bed-ridden patients. It is used to replace/deliver/infuse fluids including antibiotics, chemotherapy drugs, hydrating fluids, pain medication, hormones, or dietary infusions, among many others, in controlled amounts (small and large volumes). It is usually used for patients with chronic conditions like cancer and diabetes with approximately 1.5 million infusion pumps being inserted in US hospitals every year. Infusion pumps ensure accurate and continuous therapy in drug delivery. With rising cancer rates and cancer screening programs, many individuals will be using infusion pumps to receive medication and treatment.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure device/equipment volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Infusion Pumps and evolving competitive landscape:
Global, Regional and Country level market specific insights:
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: B. Braun Melsungen AG, Baxter International Inc, Becton Dickinson & Co, Belmont Medical Technologies, Fresenius SE & Co KGaA, ICU Medical Inc, Abbott Laboratories, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable